Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Percocet / Penicillins
 
Attending: ___.
 
Chief Complaint:
Morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy, hiatal hernia repair

 
History of Present Illness:
Per Dr. ___ has class II severe obesity with 
weight of 207.7 pounds as of ___ with her initial screen 
weight of 198.6 pounds on ___, height of 61.5 inches and 
BMI of 38.6.  Her previous weight loss efforts have included 
Weight Watchers, Slim-Fast, over-the-counter dietary supplements 
as well as prescription weight loss medication phentermine 
losing up to 60 pounds but her weight loss attempts that failed 
to produce significant and/or lasting results.  She stated that 
her lowest adult weight was 115 pounds up to the age of ___ and 
then after birth of her son she gained 70 pounds and her highest 
weight is her current weight of 207.7 pounds.  She stated that 
she has been struggling with weight for more than ___ years.  
Factors contributing to her excess weight include genetics, 
large portions, grazing, convenience eating, boredom and lack of 
exercise.  She does try to walk 5 times a week for 30 minutes.  
She denied history of eating disorders - no anorexia, bulimia, 
diuretic or laxative abuse and she denied binging.  She does not 
have a clinical diagnosis of depression except for situational 
around her weight and she has not been followed by a therapist 
nor has she been hospitalized for mental health issues and she 
is not on any psychotropic medications.

 
Past Medical History:
1)  obstructive sleep apnea recommended for CPAP
2)  severe gastroesophageal reflux by upper GI series
3)  hypertension
4)  pre-diabetes with hemoglobin A1c of 6.2%
5)  hyperlipidemia with elevated triglycerides
6)  asthma with no recent flares or prednisone taper
7)  hepatic steatosis by ultrasound study
8)  moderate size hiatal hernia
9)  vitamin D deficiency

Her surgical history is notable for:

1)  appendectomy in ___
2)  s/p c-section in ___
3)  tubal ligation in ___
4)  wisdom teeth extraction

 
Social History:
___
Family History:
Her family history is noted for both parents living father age 
___ with diabetes, hypertension, diverticular disease with colon 
resection; mother age ___ with hypertension and uterine CA; 3 
brothers ages ___, ___ and ___ all alive and well.

 
Physical Exam:
T 99.2 BP 163/104 P ___ RR ___ Ra (BP recheck 154/94)
General: no acute distress; alert and oriented x 3
Cardiac: mild tachycardia, normal rhythm, NL S1,S2, no murmurs 
appreciated
Respiratory: clear to auscultation, bilaterally; no respiratory 
distress
Abdomen: soft, non-tender, non-distended, no rebound tenderness 
or guarding; abd lap sites with steri-strips, CDI
Ext: no lower extremity edema or tenderness, bilaterally
 
Pertinent Results:
___ 06:09AM BLOOD Hct-41.1
___ 04:14PM BLOOD Hct-42.1
 
Brief Hospital Course:
 The patient presented to pre-op on ___. Patient was 
evaluated by anaesthesia.   The patient was taken to the 
operating room for a laparoscopic sleeve gastrectomy for obesity 
and hiatal hernia repair. There were no adverse events in the 
operating room; please see the operative note for details. Pt 
was extubated, taken to the PACU until stable, then transferred 
to the ward for observation.  
 Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA. Pain was 
very well controlled. The patient was then transitioned to 
crushed oral pain medication once tolerating a stage 3 diet.  
 CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.  She did have 
tachycardia with ambulation (130s) which resolved at rest.  A 1 
L LR fluid bolus was administered with good response and heart 
rate ~110 during ambulation; pt asymptomatic.
 Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization.  
 GI/GU/FEN: The patient was initially kept NPO. Afterwards, the 
patient was started on a stage 1 bariatric diet, which the 
patient tolerated well. Subsequently, the patient was advanced 
to stage 2, and then stage 3 diet which the patient was 
tolerating on day of discharge.  
 ID: The patient's fever curves were closely watched for signs 
of infection, of which there were none.  
 HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.  
 Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.  
 At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet, ambulating, voiding without assistance, 
and pain was well controlled. The patient received discharge 
teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan.  

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. MetFORMIN (Glucophage) 500 mg PO BID 
2. amLODIPine 2.5 mg PO DAILY 
3. Acyclovir 400 mg PO Q12H 
4. Omeprazole 40 mg PO DAILY 
5. Cetirizine 10 mg PO DAILY 
6. albuterol sulfate 2.5 mg/0.5 mL inhalation ASDIR 
7. albuterol sulfate 90 mcg/actuation inhalation ASDIR 

 
Discharge Medications:
1.  Acetaminophen (Liquid) 650 mg PO Q6H:PRN Pain - Mild 
RX *acetaminophen 650 mg/20.3 mL 20 ml by mouth every six (6) 
hours Disp #*300 Milliliter Refills:*0 
2.  Docusate Sodium (Liquid) 100 mg PO BID:PRN Constipation - 
First Line 
RX *docusate sodium 50 mg/5 mL 10 ml by mouth twice a day Disp 
#*200 Milliliter Refills:*0 
3.  Morphine Sulfate (Oral Solution) 2 mg/mL ___ mg PO Q4H:PRN 
Pain - Moderate 
RX *morphine 10 mg/5 mL ___ mg by mouth every four (4) hours 
Refills:*0 
4.  Acyclovir 400 mg PO Q12H  
5.  albuterol sulfate 2.5 mg/0.5 mL inhalation ASDIR  
6.  albuterol sulfate 90 mcg/actuation inhalation ASDIR  
7.  amLODIPine 2.5 mg PO DAILY  
8.  Cetirizine 10 mg PO DAILY  
9.  Omeprazole 40 mg PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity
Hiatal hernia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___, 

You have undergone a laparoscopic sleeve gastrectomy and repair 
of a hiatal hernia, recovered in the hospital and are now 
preparing for discharge for home with the following 
instructions:
Discharge Instructions: Please call your surgeon or return to 
the Emergency Department if you develop a fever greater than 101 
F, shaking chills, chest pain, difficulty breathing, pain with 
breathing, cough, a rapid heartbeat, dizziness, severe abdominal 
pain, pain unrelieved by your pain medication, a change in the 
nature or severity of your pain, severe nausea, vomiting, 
abdominal bloating, severe diarrhea, inability to eat or drink, 
foul smelling or colorful drainage from your incisions, redness, 
swelling from your incisions, or any other symptoms which are 
concerning to you.

Diet: Stay on Stage III diet until your follow up appointment; 
please refer to your work book for detailed instructions. Do not 
self- advance your diet and avoid drinking with a straw or 
chewing gum. To avoid dehydration, remember to sip small amounts 
of fluid frequently throughout the day to reach a goal of 
approximately ___ mL per day. Please note the following signs 
of dehydration: dry mouth, rapid heartbeat, feeling dizzy or 
faint, dark colored urine, infrequent urination. 

Medication Instructions:
Please refer to the medication list provided with your discharge 
paperwork for detailed instruction regarding your home and newly 
prescribed medications.  
Some of the new medications you will be taking include:
1.  Pain medication: You will receive a prescription for liquid 
oxycodone, an opioid pain medication.  This medication will make 
you drowsy and impair your ability to drive a motor vehicle or 
operate machinery safely. You MUST refrain from such activities 
while taking these medications. You may also take acetaminophen 
(Tylenol) for pain management; do not exceed 4000 mg per 24 hour 
period.
2. Constipation: This is a common side effect of opioid pain 
medication.  If you experience constipation, please reduce or 
eliminate opioid pain medication.  You may trial 2 ounces of 
light prune juice and/or a stool softener (i.e. crushed docusate 
sodium tablets), twice daily until you resume a normal bowel 
pattern.  Please stop taking this medication if you develop 
loose stools. Please do not begin taking laxatives including 
until you have discussed it with your nurse or surgeon.
3. Antacids: Please continue taking your omeprazole. Open this 
capsule and sprinkle contents onto applesauce, swallow whole. 
This medicine reduces stomach acid production. Please crush.
4. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs). Examples include, but are not limited to Aleve, 
Arthrotec, aspirin, Bufferin, diclofenac, Ecotrin, etodolac, 
ibuprofen, Indocin, indomethacin, Feldene, ketorolac, 
meclofenamate, meloxicam, Midol, Motrin, nambumetone, Naprosyn, 
Naproxen, Nuprin, oxaprozin, Piroxicam, Relafen, Toradol and 
Voltaren. These agents may cause bleeding and ulcers in your 
digestive system. If you are unclear whether a medication is 
considered an NSAID, please ask call your nurse or ask your 
pharmacist.
5.  Vitamins/ minerals: You may resume a chewable multivitamin, 
however, please discuss when to resume additional vitamin and 
mineral supplements with your bariatric dietitian.
6. Please hold metformin at this time.  Monitor your blood 
sugars four times per day; please notify your primary care 
provider of this medication chance and any high or low readings 
immediately.

Activity:
You should continue walking frequently throughout the day right 
after surgery; you may climb stairs.  
You may resume moderate exercise at your discretion, but avoid 
performing abdominal exercises or lifting items greater than10 
to 15 pounds for six weeks.

Wound Care:
You may remove any remaining gauze from over your incisions.  
You will have thin paper strips (Steri-Strips) over your 
incision; please, remove any remaining Steri-Strip seven to 10 
days after surgery.   
You may shower 48 hours following your surgery; avoid scrubbing 
your incisions and gently pat them dry.  Avoid tub baths or 
swimming until cleared by your surgeon. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Please call the doctor if you have increased pain, swelling, 
redness, cloudy, bloody or foul smelling drainage from the 
incision sites. 
Avoid direct sun exposure to the incision area for up to 24 
months.
Do not use any ointments on the incision unless you were told 
otherwise.

 
Followup Instructions:
___